Catalent Inc.

This committee's role in analyzing and scoring tax legislation directly influences corporate tax structures, investment incentives, and the overall tax burden on companies like Catalent.

This powerful committee controls taxation, trade, and entitlement spending (like Medicare), directly influencing Catalent's profitability through tax policy, supply chain costs, and pharmaceutical pricing.

This committee allocates federal discretionary spending, directly determining funding for the FDA, NIH research, and government healthcare programs, profoundly impacting Catalent's regulatory and market environment.

This committee directly regulates the FDA (primary pharmaceutical regulator), NIH (research funding), and labor laws, all of which are central to Catalent's operations and industry.

This committee oversees antitrust laws (critical for M&A and competition) and intellectual property, both of which are fundamental and highly impactful for a pharmaceutical company.